The global bone grafts & substitutes market was valued at $2,652.6 million in 2020, and is projected to reach $3,362.6 million by 2028, registering a CAGR of 4.3% from 2021 to 2028. Rise in incidences ...

Hailed as one of the most important feats of British engineering in the last 50 years, Queen Mary researchers developed a range of cost-effective synthetic bone graft materials. These innovative ...

Professor Hala Zreiqat is printing bone substitutes at the University of Sydney’s Biomaterials and Tissue Engineering Research Unit. She has developed a technique for 3D printing ceramic so it ...

The global bone grafts and substitutes market was valued at over US$ 3 billion in 2020 and is projected to expand at a compound annual growth rate (CAGR) of 4.9% from 2021 to 2028. By the end of 2028, ...

The growing prevalence of orthopaedic conditions is boosting the market’s demand. South Korea’s bone graft and substitutes ...

Novadip Biosciences’s bone grafting material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase Ib/IIa proof-of-concept study. The Belgian company’s NVDX3-CLN01 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel synthetic bone graft showed noninferiority ...

SALT LAKE CITY, March 12, 2025 /PRNewswire/ -- For the thousands of patients in the United States requiring treatment for bone loss or defects caused by trauma or infections, Elute, Inc.

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company ...